AChE and RACK1 Promote the Anti-Inflammatory Properties of Fluoxetine
暂无分享,去创建一个
G. Hartmann | O. Livnah | H. Soreq | N. Waiskopf | U. Bekenstein | A. Gilboa-Geffen | Estelle R. Bennett | K. Ofek | Assaf Bahat | E. Podoly | Adi Gilboa-Geffen | Uriya Bekenstein
[1] B. Kolisnyk,et al. Regulation of cholinergic activity by the vesicular acetylcholine transporter. , 2013, The Biochemical journal.
[2] Y. Mineur,et al. Cholinergic signaling in the hippocampus regulates social stress resilience and anxiety- and depression-like behavior , 2013, Proceedings of the National Academy of Sciences.
[3] U. Heinemann,et al. Fluoxetine induces vasodilatation of cerebral arterioles by co-modulating NO/muscarinic signalling , 2012, Journal of cellular and molecular medicine.
[4] Ramyavardhanee Chandrasekaran,et al. Structure of human Rack1 protein at a resolution of 2.45 Å. , 2012, Acta crystallographica. Section F, Structural biology and crystallization communications.
[5] Ryan G. Coleman,et al. ZINC: A Free Tool to Discover Chemistry for Biology , 2012, J. Chem. Inf. Model..
[6] A. Taly,et al. α7-Nicotinic acetylcholine receptors: an old actor for new different roles. , 2012, Current drug targets.
[7] B. Hoebel,et al. Corticotropin-releasing factor in the nucleus accumbens shell induces swim depression, anxiety, and anhedonia along with changes in local dopamine/acetylcholine balance , 2012, Neuroscience.
[8] H. Soreq,et al. Post-traumatic anxiety associates with failure of the innate immune receptor TLR9 to evade the pro-inflammatory NFκB pathway , 2012, Translational Psychiatry.
[9] G. Hartmann,et al. Stressing hematopoiesis and immunity: an acetylcholinesterase window into nervous and immune system interactions , 2012, Front. Mol. Neurosci..
[10] J. Leza,et al. Origin and consequences of brain Toll-like receptor 4 pathway stimulation in an experimental model of depression , 2011, Journal of Neuroinflammation.
[11] Zhiping Weng,et al. Accelerating Protein Docking in ZDOCK Using an Advanced 3D Convolution Library , 2011, PloS one.
[12] De-xiang Liu,et al. Anti-inflammatory effects of fluoxetine in lipopolysaccharide(LPS)-stimulated microglial cells , 2011, Neuropharmacology.
[13] Michelle R. Lennartz,et al. Protein Kinase C and Toll-Like Receptor Signaling , 2011, Enzyme research.
[14] G. Baillie,et al. Interaction with receptor for activated C-kinase 1 (RACK1) sensitizes the phosphodiesterase PDE4D5 towards hydrolysis of cAMP and activation by protein kinase C , 2010, The Biochemical journal.
[15] J. Sussman,et al. Acetylcholinesterase: from 3D structure to function. , 2010, Chemico-biological interactions.
[16] B. Leonard. The concept of depression as a dysfunction of the immune system. , 2010, Current immunology reviews.
[17] S. Maier,et al. Evidence that tricyclic small molecules may possess toll-like receptor and myeloid differentiation protein 2 activity , 2010, Neuroscience.
[18] S. Akira,et al. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors , 2010, Nature Immunology.
[19] D. Ron,et al. Epigenetic Regulation of BDNF Expression via the Scaffolding Protein RACK1* , 2010, The Journal of Biological Chemistry.
[20] F. Brennan,et al. Fluoxetine and citalopram exhibit potent antiinflammatory activity in human and murine models of rheumatoid arthritis and inhibit toll-like receptors. , 2010, Arthritis and rheumatism.
[21] H. Soreq,et al. MicroRNA-132 potentiates cholinergic anti-inflammatory signaling by targeting acetylcholinesterase. , 2009, Immunity.
[22] Kevin J. Tracey,et al. The Neurology of the Immune System: Neural Reflexes Regulate Immunity , 2009, Neuron.
[23] A. Olson,et al. AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading , 2009, J. Comput. Chem..
[24] Hayyoung Lee,et al. The structural basis of lipopolysaccharide recognition by the TLR4–MD-2 complex , 2009, Nature.
[25] A. Ferry,et al. Effect of fluoxetine on neuromuscular function in acetylcholinesterase (AChE) knockout mice. , 2008, Chemico-biological interactions.
[26] K. Miyake,et al. TLR accessory molecules. , 2008, Current opinion in immunology.
[27] E. Moilanen,et al. Inhibition of protein kinase C βII downregulates tristetraprolin expression in activated macrophages , 2008, Inflammation Research.
[28] Y. Ben-Shaul,et al. Acetylcholinesterase/C terminal binding protein interactions modify Ikaros functions, causing T lymphopenia , 2007, Leukemia.
[29] P. Scully,et al. Plasma cytokine profiles in depressed patients who fail to respond to selective serotonin reuptake inhibitor therapy. , 2007, Journal of psychiatric research.
[30] F. Mora,et al. Stress, prefrontal cortex and environmental enrichment: Studies on dopamine and acetylcholine release and working memory performance in rats , 2007, Behavioural Brain Research.
[31] R. Medzhitov,et al. Phosphoinositide-Mediated Adaptor Recruitment Controls Toll-like Receptor Signaling , 2006, Cell.
[32] H. Soreq,et al. Stress-induced cholinergic signaling promotes inflammation-associated thrombopoiesis. , 2006, Blood.
[33] H. Soreq,et al. RACK1 has the nerve to act: Structure meets function in the nervous system , 2006, Progress in Neurobiology.
[34] H. Soreq,et al. Hydrolytic and Nonenzymatic Functions of Acetylcholinesterase Comodulate Hemopoietic Stress Responses1 , 2006, The Journal of Immunology.
[35] J. Frank,et al. Regulation of eukaryotic translation by the RACK1 protein: a platform for signalling molecules on the ribosome , 2004, EMBO reports.
[36] J. Sussman,et al. The synaptic acetylcholinesterase tetramer assembles around a polyproline II helix , 2004, The EMBO journal.
[37] K. Tang,et al. Spatial and Temporal Regulation of RACK1 Function and N-methyl-D-aspartate Receptor Activity through WD40 Motif-mediated Dimerization* , 2004, Journal of Biological Chemistry.
[38] A. Tarakhovsky,et al. Essential role of Src-family protein tyrosine kinases in NF-κB activation during B cell development , 2003, Nature Immunology.
[39] H. Soreq,et al. Interaction of “readthrough” acetylcholinesterase with RACK1 and PKCβII correlates with intensified fear-induced conflict behavior , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[40] Kevin J. Tracey,et al. The inflammatory reflex , 2002, Nature.
[41] M. Goldman,et al. Critical role of protein kinase C ϵ for lipopolysaccharide‐induced IL‐12 synthesis in monocyte‐derived dendritic cells , 2002, European journal of immunology.
[42] N. Brandon,et al. Receptor for Activated C Kinase-1 Facilitates Protein Kinase C-Dependent Phosphorylation and Functional Modulation of GABAA Receptors with the Activation of G-Protein-Coupled Receptors , 2002, The Journal of Neuroscience.
[43] F. Golley,et al. Structure and Function , 2002, Science's STKE.
[44] D. Mochly‐Rosen,et al. Binding Specificity for RACK1 Resides in the V5 Region of βII Protein Kinase C* , 2001, The Journal of Biological Chemistry.
[45] H. Soreq,et al. Acetylcholinesterase — new roles for an old actor , 2001, Nature Reviews Neuroscience.
[46] P. Renshaw,et al. Increased orbitofrontal cortex levels of choline in depressed adolescents as detected by in vivo proton magnetic resonance spectroscopy , 2000, Biological Psychiatry.
[47] Edwin J. Weeber,et al. A Role for the β Isoform of Protein Kinase C in Fear Conditioning , 2000, The Journal of Neuroscience.
[48] K. Tracey,et al. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin , 2000, Nature.
[49] A. Altman,et al. NF-kappa B activation induced by T cell receptor/CD28 costimulation is mediated by protein kinase C-theta. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[50] N. Brandon,et al. Subunit-Specific Association of Protein Kinase C and the Receptor for Activated C Kinase with GABA Type A Receptors , 1999, The Journal of Neuroscience.
[51] I. Diamond,et al. Coordinated Movement of RACK1 with Activated βIIPKC* , 1999, The Journal of Biological Chemistry.
[52] Yoshinori Nagai,et al. MD-2, a Molecule that Confers Lipopolysaccharide Responsiveness on Toll-like Receptor 4 , 1999, The Journal of experimental medicine.
[53] T. Kodadek,et al. Chemistry for the analysis of protein-protein interactions: rapid and efficient cross-linking triggered by long wavelength light. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[54] M F Sanner,et al. Python: a programming language for software integration and development. , 1999, Journal of molecular graphics & modelling.
[55] C. Chen,et al. Antisense oligonucleotides targeting protein kinase C-alpha, -beta I, or -delta but not -eta inhibit lipopolysaccharide-induced nitric oxide synthase expression in RAW 264.7 macrophages: involvement of a nuclear factor kappa B-dependent mechanism. , 1998, Journal of immunology.
[56] R. Miledi,et al. Effects of fluoxetine on wild and mutant neuronal α7 nicotinic receptors , 1998, Molecular Psychiatry.
[57] A. Rush,et al. Are fluoxetine plasma levels related to outcome in obsessive-compulsive disorder? , 1996, The American journal of psychiatry.
[58] A. Tarakhovsky,et al. Immunodeficiency in Protein Kinase Cβ-Deficient Mice , 1996, Science.
[59] J. Rybakowski,et al. Interleukin‐6 Serum Levels in Depressed Patients before and after Treatment with Fluoxetine , 1995, Annals of the New York Academy of Sciences.
[60] K. Krishnan,et al. Brain choline in depression: In vivo detection of potential pharmacodynamic effects of antidepressant therapy using hydrogen localized spectroscopy , 1994, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[61] F. Liew,et al. Inhibition of nitric oxide synthesis by interleukin‐4 may involve inhibiting the activation of protein kinase C epsilon , 1994, European journal of immunology.
[62] J. Caldwell,et al. Cloning of an intracellular receptor for protein kinase C: a homolog of the beta subunit of G proteins. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[63] D. Kioussis,et al. Accelerated proliferation and interleukin-2 production of thymocytes by stimulation of soluble anti-CD3 monoclonal antibody in transgenic mice carrying a rabbit protein kinase C alpha. , 1992, The Journal of biological chemistry.
[64] D. Mochly‐Rosen,et al. Intracellular receptors for activated protein kinase C. Identification of a binding site for the enzyme. , 1991, The Journal of biological chemistry.
[65] D. Sax,et al. Cholinergic-adrenergic hypothesis of mania and depression. , 1972, Lancet.
[66] Comparative Effectiveness Review Number 62 Treatment for Depression After Unsatisfactory Response to SSRIs Executive Summary , 2012 .
[67] R. Dantzer,et al. From inflammation to sickness and depression: when the immune system subjugates the brain , 2008, Nature Reviews Neuroscience.
[68] Y. Nishizuka,et al. The family of protein kinase C and membrane lipid mediators. , 2002, Journal of diabetes and its complications.
[69] D. Mochly‐Rosen,et al. Binding specificity for RACK1 resides in the V5 region of beta II protein kinase C. , 2001, The Journal of biological chemistry.
[70] J. Sweatt,et al. A role for the beta isoform of protein kinase C in fear conditioning. , 2000, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[71] I. Diamond,et al. Coordinated movement of RACK1 with activated betaIIPKC. , 1999, The Journal of biological chemistry.
[72] R. Miledi,et al. Effects of fluoxetine on wild and mutant neuronal alpha 7 nicotinic receptors. , 1998, Molecular psychiatry.
[73] N. Guex,et al. SWISS‐MODEL and the Swiss‐Pdb Viewer: An environment for comparative protein modeling , 1997, Electrophoresis.
[74] A. Tarakhovsky,et al. Immunodeficiency in protein kinase cbeta-deficient mice. , 1996, Science.
[75] T. Hennigan,et al. Erythropoietin and autologous blood donation. Reply , 1989 .